1. Home
  2. SAGE vs GNTY Comparison

SAGE vs GNTY Comparison

Compare SAGE & GNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • GNTY
  • Stock Information
  • Founded
  • SAGE 2010
  • GNTY 1913
  • Country
  • SAGE United States
  • GNTY United States
  • Employees
  • SAGE N/A
  • GNTY N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • GNTY Major Banks
  • Sector
  • SAGE Health Care
  • GNTY Finance
  • Exchange
  • SAGE Nasdaq
  • GNTY Nasdaq
  • Market Cap
  • SAGE 474.6M
  • GNTY 450.9M
  • IPO Year
  • SAGE 2014
  • GNTY 2017
  • Fundamental
  • Price
  • SAGE $7.37
  • GNTY $38.00
  • Analyst Decision
  • SAGE Hold
  • GNTY Hold
  • Analyst Count
  • SAGE 19
  • GNTY 3
  • Target Price
  • SAGE $9.88
  • GNTY $37.33
  • AVG Volume (30 Days)
  • SAGE 1.2M
  • GNTY 28.2K
  • Earning Date
  • SAGE 04-24-2025
  • GNTY 04-21-2025
  • Dividend Yield
  • SAGE N/A
  • GNTY 2.46%
  • EPS Growth
  • SAGE N/A
  • GNTY 7.03
  • EPS
  • SAGE N/A
  • GNTY 2.74
  • Revenue
  • SAGE $41,243,000.00
  • GNTY $120,816,000.00
  • Revenue This Year
  • SAGE $100.39
  • GNTY $8.05
  • Revenue Next Year
  • SAGE $70.86
  • GNTY $4.48
  • P/E Ratio
  • SAGE N/A
  • GNTY $14.84
  • Revenue Growth
  • SAGE N/A
  • GNTY 1.11
  • 52 Week Low
  • SAGE $4.62
  • GNTY $27.01
  • 52 Week High
  • SAGE $17.51
  • GNTY $42.95
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 40.58
  • GNTY 38.20
  • Support Level
  • SAGE $7.99
  • GNTY $39.07
  • Resistance Level
  • SAGE $7.97
  • GNTY $40.69
  • Average True Range (ATR)
  • SAGE 0.31
  • GNTY 1.16
  • MACD
  • SAGE -0.10
  • GNTY -0.13
  • Stochastic Oscillator
  • SAGE 1.37
  • GNTY 0.00

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About GNTY Guaranty Bancshares Inc.

Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.

Share on Social Networks: